Clinical trial
Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
NCT03782818 is registered in ClinicalTrials.gov with Laval University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
- Lead sponsor
- Laval University
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- November 20, 2019
- Completion date
- October 31, 2024
- Enrollment
- 17 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.